COVID-19

Showing NaN - NaN of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19, Vaccine Trial in Baltimore (REDES, Control)

Recruiting
  • COVID-19
  • Vaccine
  • REDES
  • Control
  • Baltimore, Maryland
    Johns Hopkins University
Nov 10, 2023

COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)

Recruiting
  • COVID-19
  • +3 more
  • RQ-001
  • Placebo
  • Cullman, Alabama
  • +8 more
Sep 28, 2023

COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))

Not yet recruiting
  • COVID-19
  • XBB.1.5 Vaccine (Booster)
  • XBB.1.5 Vaccine (single dose)
  • Mobile, Alabama
  • +29 more
Aug 4, 2023

COVID-19, COVID Long-Haul Trial in Baltimore (Magnetic Resonance Imaging, Ultra-High Resolution Computed Tomography (CT) Scan)

Enrolling by invitation
  • COVID-19
  • COVID Long-Haul
  • Magnetic Resonance Imaging
  • Ultra-High Resolution Computed Tomography (CT) Scan
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
Jun 23, 2023

COVID-19 Trial in Baltimore (Emetine Hydrochloride, Placebo)

Not yet recruiting
  • COVID-19
  • Emetine Hydrochloride
  • Placebo
  • Baltimore, Maryland
    Johns Hopkins University, The Center for TB and AIDS Research
Jun 9, 2023

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Baltimore (Intervention test)

Enrolling by invitation
  • COVID-19
  • Intervention test
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Mar 13, 2023

Vaccination Refusal, COVID-19 Trial in Baltimore (Factual messages, Narrative message, Mixed message)

Completed
  • Vaccination Refusal
  • COVID-19
  • Factual messages
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Mar 1, 2023

SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in

Recruiting
  • COVID-19
    • Baltimore, Maryland
    • +1 more
    Feb 2, 2023

    COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

    Recruiting
    • COVID-19
    • +2 more
    • Birmingham, Alabama
    • +68 more
    Jan 24, 2023

    B- and T-cell Repertoire and Immune Response in Acute and

    Recruiting
    • COVID-19
      • Washington, District of Columbia
      • +3 more
      Jan 24, 2023

      COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)

      Completed
      • COVID-19
      • +2 more
      • pathogen reduced SARS-CoV-2 convalescent plasma
      • Placebo
      • Little Rock, Arkansas
      • +25 more
      Oct 6, 2022

      Infection Viral, Thromboses, Venous, COVID-19 Trial in United States (Enoxaparin Prefilled Syringe [Lovenox])

      Completed
      • Infection Viral
      • +2 more
      • Enoxaparin Prefilled Syringe [Lovenox]
      • Birmingham, Alabama
      • +15 more
      Sep 15, 2022

      SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

      Completed
      • SARS-CoV Infection
      • +3 more
      • Moderna COVID-19 Vaccine
      • +2 more
      • Tucson, Arizona
      • +28 more
      Sep 19, 2022

      COVID-19 Trial in Worldwide (Remdesivir)

      Recruiting
      • COVID-19
      • Birmingham, Alabama
      • +36 more
      Aug 18, 2022

      COVID-19 Trial in United States (Ad26.COV2.S, BNT162b2, mRNA-1273)

      Recruiting
      • COVID-19
      • Ad26.COV2.S
      • +4 more
      • Atlanta, Georgia
      • +11 more
      Aug 11, 2022

      Intensive Care Survivors of Coronavirus Disease (COVID-19)

      Recruiting
      • COVID-19
        • Baltimore, Maryland
        • +1 more
        Aug 8, 2022

        COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)

        Active, not recruiting
        • COVID-19
        • SARS-CoV-2
        • AZD1222
        • Placebo
        • Phoenix, Arizona
        • +83 more
        Jul 13, 2022

        SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

        Recruiting
        • SARS-CoV-2 Infection
        • COVID-19
        • BNT162b2
        • +4 more
        • Athens, Alabama
        • +158 more
        Jul 18, 2022

        SARS-CoV-2 Specific CD8 T Cells in Humans

        Recruiting
        • COVID-19
          • Baltimore, Maryland
            National Institute of Aging, Clinical Research Unit
          Jul 6, 2022